IM Cannabis Q1 EPS $(0.31) Misses $(0.20) Estimate, Sales $8.95M Miss $10.60M Estimate
Portfolio Pulse from Benzinga Newsdesk
IM Cannabis (NASDAQ:IMCC) reported Q1 losses of $(0.31) per share, missing the $(0.20) estimate by 55%, and a 1650% decrease from last year's earnings. Sales were $8.95M, missing the $10.60M estimate by 15.58%, and down 8.16% from last year.
May 08, 2024 | 12:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IM Cannabis reported significant misses in both EPS and sales for Q1, with a 55% miss on EPS estimates and a 15.58% miss on sales estimates.
The significant miss in both earnings per share and sales compared to analyst estimates, coupled with a substantial decrease from the previous year's performance, is likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100